CSL (ASX:CSL) to build a new vaccine manufacturing plant
16 Nov 2020 - Global biotechnology leader CSL (ASX:CSL) today announced that Seqirus, a wholly owned subsidiary of CSL, plans to invest more than $800 million in the construction of a new biotech manufacturing facility in Melbourne.